Patents by Inventor Daniel E. Salazar

Daniel E. Salazar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220075667
    Abstract: In an embodiment, a method includes receiving user-behavior data for a plurality of software applications. The method also includes determining activity windows for the plurality of software applications. The method also includes generating a time map of the activity windows. The method also includes detecting a usage pattern, where the usage pattern indicates two or more applications of the plurality of software applications that are used in combination. The method also includes identifying a user-centric workload from the usage pattern. The method also includes generating a user-centric workload specification for the user-centric workload, where the user-centric workload identifies the two or more applications indicated by the usage pattern. The method also includes associating the user-centric workload specification with an optimization trigger and an optimization profile. The method also includes optimizing the user-centric workload in accordance with the optimization trigger and the optimization profile.
    Type: Application
    Filed: August 17, 2021
    Publication date: March 10, 2022
    Applicant: ASURVIO, LP
    Inventors: Brett Pany, Bogdan Odulinski, Daniel E. Salazar
  • Patent number: 6008222
    Abstract: An improved method for orally administering buspirone to a human subject wherein the bioavailability of buspirone is increased and its elimination, metabolite formation, and variability of these pharmacokinetic parameters is decreased, the improvement comprises the concurrent administration of a sufficient amount of nefazodone to effect these pharmacokinetic changes for orally administered buspirone.
    Type: Grant
    Filed: November 6, 1997
    Date of Patent: December 28, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventor: Daniel E. Salazar